USPTO serial 97394555
SOLA
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- NELMAN, JESSE M
- Law office
- TMO LAW OFFICE 129
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SOLA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Mueller
John Mueller BAKER & HOSTETLER LLP312 Walnut StreetSuite 3200Cincinnati, OH 45202-4074Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic biomarker reagents for medical purposes used in connection with a cervical swab to identify gynaecologic cancers of the cervix, uterine body, ovary and breast; diagnostic kits comprised of medical assays for testing bodily fluids, bodily tissue and blood for use in disease detection, namely, gynecological cancer and, in particular, cervical, uterine, ovarian and breast cancers; diagnostic reagents in kit form for conducting assays for medical purposes; medical in vitro diagnostic reagents for polymerase chain reaction (pcr) technologies; medical diagnostic reagents; epigenetic test kits comprising reagents for testing and analysing bodily fluids, bodily tissue and blood for the diagnosis and detection of cancer; reagents and kits of reagents for preparing molecules, devices, consumables, and instruments for the generation of sequencing data, genomic data, cytogenetic data, cytogenomic data, epigenetic data, genome physical structure data, genome temporal relationship data, genome spatial relationship data, subnucleus structure data, cytosol structure data, cellular organelle data, cell structure data, and cell morphology data for genomic research, medical research, and medical diagnostic use | ACTIVE | — |
| 010 | Medical apparatus for diagnostic testing of biological samples, namely, bodily fluids, body tissues and blood for the detection of cancer and disease; medical diagnostic apparatus for use in analytical tests for detecting cancer and disease from sample bodily fluids, bodily tissue and blood; instruments for making cervical smears; clinical diagnosis apparatus, namely, assays for testing of dna and epigenetics tests; dna and epigenetics testing apparatus for medical use; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations in relation to gynecological cancers of the cervix, uterine body, ovary and breast | ACTIVE | — |
| 042 | Scientific research for chemical, biochemical, biological or bacteriological purposes; scientific research for medical purposes; scientific and medical research services; electronic data storage services; scientific and technological services and research and design relating thereto, namely, dna analysis services for scientific research purposes, scientific research consulting in the field of genetics; laboratory analysis in the field of chemistry; laboratory testing services in connection with the testing of bodily fluids, bodily tissue and blood for use in disease detection, namely, gynecological cancer and, in particular, cervical, uterine, ovarian and breast cancers ;development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research and analysis of data generated by scientific and medical experiments and tests being data for the diagnosis of disease, detection and identification of pathogens, for the detection of acquired or inherited genetic mutations and detection and analysis of epigenetic alterations, analysis of response to therapy; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of acquired or inherited genetic mutations, and for detection and analysis of epigenetic alterations; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to research and development in the field of cancer diagnosis and detection | ACTIVE | — |
| 044 | Medical diagnostic services; medical testing services; medical diagnostic testing relating to the human body; blood testing services; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular testing and analysis services and DNA/RNA sequencing services for medical purposes; information, consultation and advisory services relating to medical diagnostic apparatus, instruments, preparations, products and testing; all of the foregoing for medical and research professionals and expressly excluding information in the fields of health and wellness | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 27, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 27, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Nov 28, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 27, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 20, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 20, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 5, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 5, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 5, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 5, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 19, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 16, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 19, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 19, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 19, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2023 | ALIE | ASSIGNED TO LIE | — |
| Mar 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 9, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2022 | NWAP | NEW APPLICATION ENTERED | — |